Research Topics
| Nicolai LohseSummaryAffiliation: Aarhus University Hospital Country: Denmark Publications
| Collaborators
|
Detail Information
Publications
Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failureNicolai Lohse
Department of Clinical Epidemiology, Arhus University Hospital, Arhus, Denmark
Antivir Ther 12:909-17. 2007..To examine the prevalence of drug-resistance-associated mutations in HIV patients with triple-drug class virological failure (TCF) and their association with long-term mortality...
Implementation and effectiveness of antiretroviral therapy in GreenlandNicolai Lohse
Department of Clinical Epidemiology, Arhus University Hospital, Arhus, Denmark
Emerg Infect Dis 14:56-9. 2008..However, implementation and quality of care improved considerably in recent years...- Improved survival in HIV-infected persons: consequences and perspectivesNicolai Lohse
Department of Clinical Epidemiology, Arhus University Hospital, DK 8000 Arhus C, Denmark
J Antimicrob Chemother 60:461-3. 2007.... - [Stable long-term effect of HIV therapy. The Danish Society for Infectious Diseases]Nicolai Lohse
Klinisk Epidemiologisk Afdeling, Arhus Universitetshospital, DK-8000 Arhus C
Ugeskr Laeger 169:1109. 2007 - Survival of persons with and without HIV infection in Denmark, 1995-2005Nicolai Lohse
Department of Infectious Diseases, Odense University Hospital and University of Southern Denmark, Odense, Denmark
Ann Intern Med 146:87-95. 2007..The expected survival of HIV-infected patients is of major public health interest... 
Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort studyOle S Sogaard
Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
Clin Infect Dis 47:1345-53. 2008..We compared incidence rates of pneumonia among individuals with and without HIV infection and explored risk factors for pneumonia in the HIV-infected population...- Declining prevalence of HIV-infected individuals at risk of transmitting drug-resistant HIV in Denmark during 1997-2004Nicolai Lohse
Odense University Hospital and University of Southern Denmark, Odense, Denmark
Antivir Ther 11:591-600. 2006..5%) in our population, we estimated acquisition of HIV drug resistance and examined temporal trends in the prevalence of patients at risk of transmitting drug-resistant HIV... - Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort StudyNicolai Lohse
Department of Infectious Diseases, Odense University Hospital and University of Southern Denmark, Odense, Denmark
Scand J Infect Dis 37:338-43. 2005..In this period 14.5% had AIDS at the time of HIV diagnosis. Our data do not confirm concerns about unmonitored evolution in the HIV epidemic in Denmark... - Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trialOle S Søgaard
Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
Clin Infect Dis 51:42-50. 2010..We hypothesized that adding CPG 7909, a toll-like receptor 9 (TLR9) agonist and vaccine adjuvant, to 7-valent pneumococcal conjugate vaccine (7vPnC) would increase its immunogenicity in HIV-infected adults... - Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virusAnn Brit Eg Hansen
Department of Infectious Diseases, Odense University Hospital, Odense, Denmark
PLoS ONE 2:e738. 2007..This indicates that risk factors shared by family members partially account for the excess mortality of HIV/HCV-co-infected patients. We aimed to explore the causes of death contributing to the excess sibling mortality... - Declining risk of triple-class antiretroviral drug failure in Danish HIV-infected individualsNicolai Lohse
Odense University Hospital, and University of Southern Denmark, Odense, Denmark
AIDS 19:815-22. 2005..To analyse the incidence, prevalence, and predictors for development of triple-class antiretroviral drug failure (TCF) in individuals infected with HIV... - Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up studyNicolai Lohse
Department of Infectious Diseases, Odense University Hospital, Odense, Denmark
Clin Infect Dis 42:136-44. 2006.... - Comorbidity acquired before HIV diagnosis and mortality in persons infected and uninfected with HIV: a Danish population-based cohort studyNicolai Lohse
Department of Clinical Epidemiology, Arhus University Hospital, Arhus, Denmark
J Acquir Immune Defic Syndr 57:334-9. 2011..We aimed to estimate the impact of comorbidity acquired before HIV diagnosis on mortality in individuals infected with HIV... - Mortality after hospitalization for pneumonia among individuals with HIV, 1995-2008: a Danish cohort studyOle S Søgaard
Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
PLoS ONE 4:e7022. 2009..HIV-infected persons are at increased risk of pneumonia, even with highly active antiretroviral treatment (HAART). We examined the impact of pneumonia on mortality and identified prognostic factors for death among HIV-infected... - Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infectionOle S Søgaard
Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark
PLoS ONE 7:e32538. 2012..Early identification of persons with undiagnosed HIV infection is an important health care issue. We examined associations between diseases diagnosed in hospitals and risk of subsequent HIV diagnosis... - Low effectiveness of highly active antiretroviral therapy and high mortality in the Greenland HIV-infected populationNicolai Lohse
Department of Infectious Diseases, Odense University Hospital, 5000 Odense, Denmark
Scand J Infect Dis 36:738-42. 2004..Our findings underline the difficulties of implementing successful HIV treatment even with unlimited economic resources and free access to health care... - Pneumococcal conjugate vaccination in persons with HIV: the effect of highly active antiretroviral therapyOle S Søgaard
Department of Infectious Diseases, Aarhus University Hospital, Denmark
AIDS 24:1315-22. 2010..We aimed to determine HAART's impact on seven-valent pneumococcal conjugate (7vPnC) vaccine immunization with or without a Toll-like receptor 9 (TLR9) agonist adjuvant... - Short communication: high prevalence of drug-resistant human immunodeficiency virus type 1 in treatment-naïve patients in GreenlandTina Vasehus Madsen
Statens Serum Institut, Department of Virology, Copenhagen, Denmark
AIDS Res Hum Retroviruses 24:1073-7. 2008.... - [Changes in immunological status among newly-diagnosed HIV-infected in Denmark 1995-2005]Simon Høegh
Odense Universitetshospital, Medicinsk afdeling C
Ugeskr Laeger 170:740-4. 2008.... - Confounding may lead to overestimation of pneumococcal polysaccharide vaccine effectiveness among HIV-infected individualsOle S Sogaard
Clin Infect Dis 47:294-5; author reply 295-6. 2008 - [Male circumcision--an evidence-based preventive measure]Nicolai Lohse
Ugeskr Laeger 170:2359; author reply 2360. 2008 - [Four years--an impossible respite?]Nicolai Lohse
Ugeskr Laeger 169:2240; author reply 2240. 2007 - Introduction of HIV type 1 into an isolated population: molecular epidemiologic study from GreenlandTina V Madsen
Department of Virology, Statens Serum Institut, Copenhagen, Denmark
AIDS Res Hum Retroviruses 23:675-81. 2007..The large diversity between the main Greenland cluster and the rest of the sequences is most likely due to a founder effect...